Gastro Health will use Iterative’s AI recruitment technology to recruit patients for clinical trials in inflammatory bowel disease.
The partnership will help Gastro Health better standardize endoscopy scoring during IBD trial recruitment, streamlining the identification of eligible candidates.
“With our commitment to improving GI care, Iterative Health is the right partner for us as we streamline our clinical trials,” Pradeep Bekal, MD, vice president of clinical affairs for Gastro Health Ohio, said in a Dec. 13 press release. “As we continue to expand our clinical research program, we’re looking forward to improving our trial recruitment efforts with more accurate patient screening and identification, and ultimately, increasing patient access to trials and care.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.